Ok lets crunch some numbers, very rough of course.
Global BV market estimated to be 1 billion.
Assumptions:
1. We will not be marketed globally.
2. We will not have 100% market penetration.
3. We will not get 100% of the revenue, we will likely get circa 8% (very rough estimation that others can subsitute).
So what % of the global market do we expect to access? I'll give it a generous 50% weighting.
% market penetration i'll give it a generous 70%
8% cut of sales.
500 000 000 x 0.7 . 0.08 = $28 million in revenue for us per year in full swing.
Before we get to full swing I estimate we get 2/5ths of well you know what.
Please create your own formulae's of potential revenue to share from Vivagel, I'll be greatly interested to see your own estimates.
- Forums
- ASX - By Stock
- SPL
- BV market for prevention
SPL
starpharma holdings limited
Add to My Watchlist
0.70%
!
72.0¢
BV market for prevention
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.